ArticleCancer immunology, immunotherapy : CII2014

Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.

Wen-Juan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.